Tech Company Financing Transactions

Nucleus Genomics Funding Round

Seven Seven Six, Founders Fund and private investors participated in a $14 million Seed funding round for Nucleus Genomics. The financing round was announced on 7/15/2022.

Transaction Overview

Company Name
Announced On
7/15/2022
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Seed
Investors

Seven Seven Six (Lead Investor) (Alexis Ohanian)

Founders Fund

private investors (Adrian Aoun)

private investors (Alexandra Botez)

private investors (Anthony Pompliano)

private investors (Austen Allred)

private investors (Brent Saunders)

private investors (Hugo Barra)

private investors (Packy McCormick)

private investors (Patrick Hsu)

private investors (Shrug Capital)

Proceeds Purpose
We will help Nucleus bolster its scientific and engineering team.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Brooklyn, NY 11201
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Nucleus provides genetic analysis of greater breadth, depth, and beauty.
Profile
Nucleus Genomics LinkedIn Company Profile
Social Media
Nucleus Genomics Company Twitter Account
Company News
Nucleus Genomics News
Facebook
Nucleus Genomics on Facebook
YouTube
Nucleus Genomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kian Sadeghi
  Kian Sadeghi LinkedIn Profile  Kian Sadeghi Twitter Account  Kian Sadeghi News  Kian Sadeghi on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/15/2022: Accelus venture capital transaction
Next: 7/15/2022: Club venture capital transaction

 

Share this article

 


Where The Data Comes From

We document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary